Skip to main content
Premium Trial:

Request an Annual Quote

UK's Enigma Diagnostics Opens San Francisco Office

NEW YORK (GenomeWeb News) – UK-based firm Enigma Diagnostics has opened a US office in San Francisco, the company said today.
 
The office, which opened yesterday, is Enigma’s first facility outside the UK. The new office was established to commercialize the company’s rapid diagnostic instrument systems.
 
Enigma launched its first product, the Enigma Field Laboratory, in November. The FL is “a fully automated, real-time PCR detection system geared for use by veterinarians, first responders, and military personnel."
 
The company said that it has tapped Chris Melancon, a former Applied Biosystems executive, to head the new office.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.